abstract
vaccin
save
million
live
year
variou
lifethreaten
infecti
diseas
vaccin
current
licens
human
use
worldwid
moreov
recent
decad
immunotherapi
becom
mainstream
therapi
highlight
tremend
potenti
immun
respons
mediat
includ
vaccin
prevent
treatment
variou
form
cancer
howev
despit
tremend
advanc
microbiolog
immunolog
sever
vaccin
prevent
diseas
still
lack
effect
vaccin
classic
weaken
form
attenu
pathogen
microb
use
vaccin
although
attenu
microb
induc
effect
immun
respons
signific
risk
revers
pathogen
form
remain
twentyfirst
centuri
advent
genet
engin
microb
tailor
desir
properti
review
focus
use
genet
modifi
bacteria
deliveri
vaccin
antigen
specif
liveattenu
bacteria
deriv
pathogen
bacteria
possess
mani
featur
make
highli
suitabl
vector
deliveri
vaccin
antigen
bacteria
theoret
express
heterolog
gene
deliv
mammalian
express
vector
harbor
vaccin
antigen
dna
vaccin
properti
liveattenu
microb
har
make
vaccin
sever
infecti
noninfecti
diseas
regard
describ
desir
featur
liveattenu
bacteri
vector
mechan
immun
respons
manifest
liveattenu
bacteri
vector
interestingli
anaerob
bacteria
natur
attract
tumor
make
suitabl
vehicl
deliv
tumorassoci
antigen
thu
discuss
import
studi
investig
role
bacteri
vector
immunotherapi
final
provid
import
discuss
novel
approach
improv
tailor
liveattenu
bacteri
vector
gener
desir
immun
respons
vaccin
provid
protect
numer
lifethreaten
infecti
diseas
activ
adapt
immun
specif
pathogenderiv
antigen
sinc
introduct
activ
immun
sever
vaccin
licens
human
use
includ
subunit
vaccin
prefer
superior
safeti
profil
howev
success
limit
poor
immunogen
multipl
booster
immun
adjuv
requir
achiev
adequ
level
protect
immun
moreov
subunit
vaccin
applic
pathogen
welldefin
protect
antigen
discov
subunit
vaccin
also
limit
abil
induc
cellmedi
immun
contrast
liveattenuatedliveinactiv
vaccin
exhibit
superior
immunogen
induc
humor
well
cellmedi
immun
although
attenu
virus
bacteria
util
vaccin
vector
review
focu
attenu
bacteri
vaccin
vector
bacteria
harbor
natur
adjuv
form
pathogenassoci
molecular
pattern
pamp
fig
pamp
recogn
compon
innat
immun
system
includ
tolllik
receptor
tlr
facilit
releas
proinflammatori
mediat
recruit
antigenpres
cell
fig
furthermor
even
attenu
limit
degre
prolifer
dissemin
capac
retain
attenu
pathogen
overal
factor
contribut
superior
immunogen
liveattenu
bacteria
consequ
elicit
robust
durabl
immun
cognat
antigen
advent
molecular
biolog
genet
feasibl
effect
excis
insert
desir
gene
bacteria
bacteri
vector
engin
express
deliv
heterolog
protein
antigen
therapeut
protein
mammalian
host
moreov
genet
manipul
bacteri
vector
engin
properti
includ
reduc
virul
high
immunogen
properti
desir
vaccin
vector
thu
far
varieti
liveattenu
bacteri
vector
includ
mycobacterium
bovi
strain
bacillu
bcg
salmonella
spp
listeria
monocytogen
lm
vibrio
cholera
escherichia
coli
shigella
spp
util
deliveri
heterolog
protein
mammalian
host
vaccin
antigen
therapeut
protein
bacteria
call
liveattenu
bacteri
vector
labv
vaccin
elicit
distinct
immun
respons
depend
rout
immun
mucos
immun
induc
strong
system
well
mucos
immun
complement
function
copi
asd
gene
insert
plasmid
featur
ensur
antibioticfre
mainten
plasmid
plasmid
also
carri
gene
encod
antigen
protein
variou
pathogenassoci
molecular
pattern
includ
flagellin
lipopolysaccharid
lipoprotein
peptidoglycan
facilit
interact
signal
activ
antigenpres
cell
addit
appendag
like
autotransport
facilit
surfac
display
antigen
respons
wherea
parenter
immun
induc
potent
system
poor
mucos
immun
respons
sinc
birth
mucos
surfac
human
bodi
constantli
challeng
agent
extern
environ
either
complet
harmless
food
ingredi
nonpathogen
microb
pathogen
pathogen
microb
thu
order
restrict
pathogen
insult
mucos
surfac
mucosaassoci
lymphoid
tissu
malt
organ
fact
malt
constitut
largest
immun
system
human
bodi
oral
rout
favor
rout
mucos
immun
mucos
rout
includ
nasal
activ
antigenpres
cell
liveattenu
bacteri
vector
lead
adapt
immun
respons
variou
pathogenassoci
molecular
pattern
present
liveattenu
bacteri
vector
interact
tolllik
receptor
express
surfac
endosom
membran
signal
initi
interact
lead
activ
antigenpres
cell
activ
antigenpres
cell
express
costimulatori
molecul
well
enhanc
express
mhcii
costimulatori
molecul
requir
deliv
essenti
second
signal
tcell
activ
first
signal
receiv
via
tcrmhcpeptid
interact
importantli
express
activ
apc
help
migrat
drain
lymph
node
moreov
type
cytokin
direct
fate
tcell
polar
cytosol
deliveri
antigen
give
rise
ctl
respons
vagin
rectal
upon
oral
administr
antigen
travel
gastrointestin
tract
reach
mucos
induct
site
call
peyer
patch
peyer
patch
line
special
epitheli
cell
call
cell
serv
point
entri
lamina
propria
lamina
propria
dendrit
cell
take
antigen
migrat
drain
lymph
node
present
antigen
cell
special
featur
dendrit
cell
peyer
patch
mesenter
lymph
node
induc
guthom
receptor
b
cell
featur
found
dendrit
cell
cervic
lymph
node
spleen
therebi
b
cell
prime
mucos
site
destin
migrat
mucos
tissu
pasetti
et
al
fig
liveattenu
microb
exhibit
superior
abil
deliv
vaccin
antigen
mucos
immun
system
mani
deriv
natur
mucos
pathogen
includ
salmonella
spp
lm
e
coli
v
cholera
shigella
spp
review
explor
current
knowledg
labv
applic
deliveri
vaccin
antigen
mucos
immun
system
dna
vaccin
immunotherapi
mechan
immun
respons
elicit
labvbas
vaccin
recent
advanc
futur
perspect
discuss
mucos
immun
respons
elicit
liveattenu
bacteri
vector
mucos
induct
site
includ
gutassoci
lymphoid
tissu
nasalassoci
lymphoid
tissu
facilit
sampl
antigen
cell
cell
allow
passag
bacteria
mucos
epithelium
taken
antigenpres
cell
includ
dc
macrophag
apc
undergo
activ
upon
interact
liveattenu
bacteri
vector
associ
antigen
present
cell
lymphoid
follicl
drain
lymph
node
activ
cell
help
b
cell
differenti
igaproduc
plasma
cell
secret
iga
provid
effect
protect
mucos
pathogen
b
cell
prime
mucos
site
migrat
back
mucos
site
perform
effector
function
nonpathogen
commens
includ
lactic
acid
bacteria
bacillu
subtili
well
attenu
version
pathogen
bacteria
includ
salmonella
spp
e
coli
shigella
spp
lm
v
cholera
util
labv
commens
microb
gener
regard
safe
food
grade
virul
pathogen
microb
need
significantli
attenu
consid
safe
deliv
vaccin
antigen
human
fig
gener
plasmid
employ
express
heterolog
antigen
labv
plasmid
easili
manipul
e
coli
univers
tool
genet
engin
subsequ
introduc
desir
bacteri
strain
shuttl
vector
plasmid
carri
genet
element
replic
e
coli
promot
element
gene
express
bacteri
mammalian
cell
thu
mammalian
express
vector
first
manipul
propag
e
coli
deliv
via
labv
mammalian
cell
desir
antigen
express
fig
earli
day
attenu
pathogen
microb
achiev
vitro
cultiv
sever
gener
follow
evalu
virul
success
gener
classic
exampl
bcg
albert
calmett
camil
guerin
cultur
virul
strain
bovi
serial
passag
vitro
gener
attenu
strain
bcg
bcg
still
vaccin
avail
prevent
tuberculosi
subsequ
genet
analysi
reveal
bcg
lack
multipl
virul
factor
associ
bovi
zheng
et
al
similarli
search
vaccin
typhoid
fever
led
gener
attenu
live
vaccin
strain
salmonella
salmonella
enterica
serotyp
typhi
st
strain
gener
chemic
mutagenesi
wildtyp
st
strain
consider
attenu
licens
human
use
oral
vaccin
wang
et
al
howev
strain
exhibit
low
immunogen
dose
requir
achiev
adequ
level
protect
advanc
microbi
genet
genet
engin
techniqu
becom
routin
identifi
inactiv
virul
gene
interestingli
variou
auxotroph
mutant
salmonella
strain
lack
abil
synthes
aromat
amino
acid
found
avirul
hoiseth
stocker
known
salmonella
gene
product
aroa
aroc
arod
requir
biosynthesi
aromat
amino
acid
well
sever
essenti
vitamin
hoiseth
stocker
note
factor
found
mammalian
host
suffici
amount
thu
salmonella
aroa
mutant
prolifer
mammalian
host
hoiseth
stocker
har
knowledg
variou
salmonella
enterica
serovar
typhi
st
typhimurium
stm
creat
mutat
aroa
dalla
pozza
et
al
robert
et
al
arnold
et
al
aroc
khan
et
al
capozzo
et
al
arod
capozzo
et
al
sevil
et
al
aroad
strugnel
et
al
robert
et
al
notabl
st
strain
carri
aroc
arod
mutat
exhibit
residu
virul
human
wang
et
al
investig
also
target
gene
nucleotid
biosynthesi
pathway
creat
attenu
salmonella
wang
et
al
engin
salmonella
strain
mutat
guaba
operon
interfer
guanin
nucleotid
biosynthesi
result
strain
call
cvd
exhibit
safeti
profil
compar
typhoid
vaccin
strain
importantli
harbor
mutat
aroc
arod
htra
cvd
exhibit
high
level
immunogen
wang
et
al
surprisingli
st
strain
guaba
mutat
wide
util
labv
pasetti
et
al
pasetti
et
al
wang
et
al
anoth
approach
attenu
salmonella
introduc
mutat
cya
adenyl
cyclas
crp
cyclic
amp
receptor
gene
protein
transcript
regul
mani
import
gene
although
camp
found
mammalian
cell
concentr
gastrointestin
tissu
requir
salmonella
thu
cya
crp
mutant
show
reduc
virul
tacket
et
al
chen
schifferli
et
al
ferreira
oliveira
et
al
mutat
twocompon
regulatori
system
phopphoq
control
virul
gene
involv
resist
antimicrobi
peptid
nutrient
scaveng
lipid
modif
significantli
decreas
salmonella
virul
raupach
kaufmann
salmonella
strain
phopphoq
mutat
use
number
studi
labv
angelakopoulo
hohmann
kotton
et
al
galen
et
al
wang
et
al
rpo
altern
sigma
factor
regul
resist
stress
induc
gastrointestin
infect
ph
nutrient
starvat
chang
osmolar
temperatur
contain
multipl
mutat
includ
rpo
wang
et
al
ssav
compon
salmonella
type
iii
secret
system
requir
secret
gene
essenti
growth
macrophag
st
strain
contain
aroc
ssav
mutat
highli
attenu
immunogen
human
hindl
et
al
tacket
et
al
gener
mutat
htra
gene
encod
heat
shock
protein
result
strain
avirul
reduc
abil
surviv
replic
host
tissu
tacket
et
al
htra
mutant
salmonella
strain
use
multipl
studi
labv
galen
et
al
robert
et
al
pasetti
et
al
capozzo
et
al
frailleri
et
al
similarli
attenu
lm
multipl
virul
factor
target
acta
encod
surfac
protein
requir
actin
polymer
host
cell
help
intracellular
migrat
promin
target
lm
attenu
togeth
mutat
internalin
b
inlb
acta
mutat
render
lm
unabl
infect
hepatocyt
thu
strain
highli
attenu
phospholipasec
b
plcb
requir
effici
escap
phagosom
vacuol
plcb
mutant
thu
attenu
due
defect
escap
secondari
vacuol
peter
et
al
stark
et
al
steven
et
al
johnson
et
al
jia
et
al
liang
et
al
cell
wall
biosynthesi
gene
specif
dal
alanin
racemas
dat
damino
acid
aminotransferas
mutat
sever
attenu
lm
vaccin
vector
friedman
et
al
verch
et
al
jiang
et
al
im
et
al
doubl
mutant
lm
requir
dalanin
cell
wall
biosynthesi
highli
attenu
recent
mclaughlin
et
al
demonstr
delet
lm
furregul
virul
factor
frva
result
attenu
murin
model
infect
due
inabl
iron
homeostasi
mclaughlin
et
al
attenu
strain
shigella
also
use
labv
noriega
et
al
noriega
et
al
gener
guaba
mutant
shigella
highli
attenu
anim
wide
use
labv
approach
mutat
includ
delet
icsa
mediat
intraand
intercellular
spread
iuca
aerobactin
strain
highli
attenu
immunogen
ranallo
et
al
introduct
heterolog
gene
bacteri
vector
facilit
plasmid
plasmid
extrachromosom
circular
dna
introduc
bacteria
process
call
transform
gener
bacteria
maintain
plasmid
util
antibiot
resist
mechan
vitro
growth
antibiot
select
pressur
ensur
stabl
plasmid
mainten
howev
vivo
condit
lack
antibiot
select
pressur
plasmidless
bacteria
outgrow
plasmidbear
bacteria
moreov
use
antibiot
marker
also
discourag
due
risk
horizont
gene
transfer
microb
pathogen
potenti
lin
et
al
mignon
et
al
novel
antibioticfre
approach
plasmid
mainten
devis
mitig
concern
one
approach
known
balanc
lethal
system
util
mutat
essenti
gene
bacteri
chromosom
plasmid
carri
function
copi
gene
therebi
ensur
mainten
bacteria
fig
galen
et
al
gener
balanc
lethal
system
stm
base
mutat
asd
gene
asd
encod
aspart
semialdehyd
dehydrogenas
enzym
requir
biosynthesi
pathway
dap
diaminopimel
acid
essenti
compon
bacteri
cell
wall
dap
need
growth
mainten
asd
mutant
copi
asd
gene
insert
plasmid
thu
asddefici
bacteria
forc
maintain
plasmid
order
surviv
dapdepriv
condit
mammalian
tissu
result
salmonella
typhimurium
stm
base
balanc
lethal
system
exhibit
high
degre
plasmid
stabil
system
also
exhibit
stabl
express
associ
heterolog
gene
et
al
balanc
lethal
system
wide
use
variou
labv
includ
st
tacket
et
al
stm
kang
et
al
flexneri
zheng
et
al
similarli
thymidin
auxotrophi
also
util
st
bumann
et
al
stm
mignon
et
al
lactic
acid
bacteria
et
al
balanc
lethal
system
approach
plasmid
mainten
glutamin
auxotroph
v
cholera
complement
glna
gene
anoth
exampl
balanc
lethal
system
util
antibioticfre
plasmid
mainten
ryan
et
al
variou
mucos
pathogen
nonpathogen
food
grade
microb
extens
util
labv
develop
salmonella
infect
via
orogastr
rout
enter
intestin
lamina
propria
transcytosi
via
cell
present
mucos
induct
site
peyer
patch
lamina
propria
salmonella
taken
variou
phagocyt
includ
neutrophil
macrophag
dendrit
cell
infect
phagocyt
carri
salmonella
variou
organ
includ
liver
spleen
via
blood
mesenter
lymph
node
via
lymph
virul
factor
cluster
salmonella
pathogen
island
facilit
invas
surviv
prolifer
intracellular
space
macrophag
pham
mcsorley
salmonella
possess
varieti
pathogenassoci
molecular
pattern
pamp
includ
lipoprotein
lipopolysaccharid
lp
flagellin
flic
cpg
pamp
recogn
host
pattern
recognit
receptor
prr
includ
tlr
lipoprotein
lp
tlr
flic
cpg
activ
prr
lead
express
secret
cytokin
broz
et
al
proinflammatori
factor
recruit
neutrophil
macrophag
dendrit
cell
hand
upon
interact
salmonella
lp
flagellin
dendrit
cell
increas
express
matur
dendrit
cell
enhanc
capabl
process
present
antigen
migrat
tcell
area
initi
adapt
immun
respons
cognat
antigen
studi
suggest
salmonella
induc
humor
well
cellmedi
immun
respons
pham
mcsorley
angelakopoulo
hohmann
l
monocytogen
igw
et
al
pseudomona
aeruginosa
bumann
et
al
streptococcu
pneumonia
yersinia
pesti
antigenspecif
respons
gener
parasit
pathogen
includ
leishmania
mexicana
et
al
schistosoma
japonicum
chen
et
al
taenia
solium
ding
et
al
mucos
igg
iga
gener
giardia
lamblia
abdulwahid
faubert
cryptosporidium
parvum
benitez
et
al
stand
stmbase
labv
carri
relat
antigen
besid
salmonella
listeria
extens
studi
bacteria
labv
similar
salmonella
listeria
infect
begin
orogastr
infect
lm
move
across
gastrointestin
epitheli
barrier
first
attach
invad
epitheli
cell
adhes
intern
requir
lm
protein
ami
internalin
inla
respect
lamina
propria
lm
rapidli
spread
system
lm
primarili
target
liver
help
fibronectin
bind
protein
fbpa
fbpa
recogn
fibronectin
surfac
hepatocyt
point
anoth
molecul
call
internalin
inlb
facilit
lm
intern
hand
phagocyt
specif
macrophag
monocyt
recogn
lipoteicho
acid
via
scaveng
receptor
phagocytosi
lm
escap
phagocyt
vesicl
synergist
activ
listeriolysin
llo
two
phospholipas
c
plca
plcb
anoth
virul
factor
acta
actin
polymer
activ
help
lm
migrat
cell
cell
liang
et
al
lm
express
variou
tlr
agonist
includ
peptidoglycan
flagellin
bacteri
dna
induc
proinflammatori
cytokin
includ
lminduc
cell
death
result
secret
help
recruit
neutrophil
help
induct
nk
cell
cell
lm
also
induc
typei
ifn
desir
antivir
immun
evid
suggest
lm
induc
tcellmedi
immun
respons
zenewicz
shen
liang
et
al
lmcarri
viral
antigen
hivsivgag
frankel
et
al
friedman
et
al
im
et
al
jia
et
al
tvinnereim
et
al
induc
ctl
immun
respons
lmbase
labv
also
induc
neutral
antibodi
howev
limit
report
lm
labv
bacteri
parasit
pathogen
one
studi
lmcarri
coxiella
burnetii
antigen
epitop
induc
tcell
immun
respons
xiong
et
al
anoth
studi
lmcarri
francisella
tularensi
antigen
iglc
induc
produc
tcellmedi
immun
respons
bcg
attenu
bovi
also
exhibit
potenti
labv
follow
immun
bcg
interact
phagocyt
macrophag
dendrit
cell
neutrophil
variou
prr
macrophag
involv
interact
bcg
includ
howev
dendrit
cell
util
differ
set
phagocyt
receptor
includ
dcsign
dec
infect
dendrit
cell
upregul
express
mhcii
costimulatori
marker
involv
activ
adapt
immun
respons
moliva
et
al
bcg
known
induc
humor
well
tcellmedi
immun
respons
abomoelak
et
al
tcell
respons
induc
bcg
includ
polyfunct
cell
secret
tnf
moliva
et
al
bcg
express
two
tuberculosi
mtb
antigen
secret
antigen
cultur
filtrat
antigen
induc
antigenspecif
immun
respons
includ
cell
chen
et
al
antigenspecif
humor
immun
respons
induc
bcg
express
hepatitisb
surfac
antigen
rezend
et
al
bcginduc
cell
also
secret
moliva
et
al
mous
model
bcg
carri
mtb
antigen
exhibit
antigenspecif
immun
respons
hatano
et
al
pertussi
toxin
subunit
express
bcg
induc
produc
cell
complet
protect
lethal
bordetella
pertussi
challeng
nascimento
et
al
furthermor
mous
model
intracellular
pathogen
lm
bcg
express
lm
antigen
induc
tcelldepend
protect
grode
et
al
studi
demonstr
bcg
induc
longliv
mycobacteriaspecif
memori
b
cell
moreov
follow
bcg
immun
host
secret
robust
mtbspecif
serum
antibodi
includ
igg
isotyp
howev
known
specif
mucos
iga
induc
bcg
moliva
et
al
flexneri
infect
occur
orogastr
rout
colon
flexneri
cross
epitheli
layer
highli
endocyt
cell
flexneri
adher
infect
colon
epithelium
basolater
surfac
colon
epitheli
cell
engulf
flexneri
macropinocytosi
activ
ipab
ipac
releas
macropinocyt
vacuol
cytosol
mellouk
enninga
flexneri
invas
caus
activ
innat
immun
system
releas
varieti
cytokin
includ
fernandez
sansonetti
jennison
verma
though
shigella
capac
celltocel
transloc
infect
limit
lamina
propria
intestin
nt
migrat
organ
maurelli
sansonetti
lamina
propria
flexneri
phagocytos
macrophag
dendrit
cell
infect
macrophag
undergo
apoptosi
lead
releas
proinflammatori
cytokin
fernandez
sansonetti
flexneri
induc
system
mucos
antibodi
respons
includ
igm
igg
secretori
iga
jennison
verma
flexneri
guaba
mutat
cvd
limit
invas
prolif
capac
attenu
flexneri
express
etec
antigen
cfai
ltb
induc
antigenspecif
serum
igg
mucos
iga
koprowski
et
al
barri
et
al
strain
et
al
ranallo
et
al
zheng
et
al
food
grade
bacteria
includ
b
subtili
lactobacillu
lacti
consid
import
candid
labv
due
superior
safeti
profil
upon
oral
administr
b
subtili
spore
safe
transit
stomach
germin
prolifer
upper
intestin
final
undergo
resporul
colon
cut
et
al
nevertheless
mechan
immun
respons
respons
b
subtili
deliv
antigen
fulli
understood
antigen
deliv
b
subtili
shown
induc
humor
well
immun
respons
cut
et
al
b
subtili
use
labv
variou
bacteri
parasit
pathogen
includ
pathogen
e
coli
h
pylori
mtb
clonorchi
sinensi
japonicum
b
subtili
induc
system
igg
amuguni
tzipori
zhou
et
al
mucos
iga
amuguni
tzipori
zhou
et
al
sibley
et
al
stasilojc
et
al
immun
respons
cognat
antigen
lactic
acid
bacteria
among
microb
occur
physiolog
anim
digest
tract
like
natur
microflora
metabolit
interact
macrophag
stimul
cytokin
product
peptidoglycan
lactic
acid
bacteria
induc
secret
tnf
monocyt
et
al
szatraj
et
al
unlik
attenu
strain
otherwis
pathogen
microb
use
labv
b
subtili
l
lacti
invad
gut
mucosa
serv
mainli
protein
antigen
factori
suppli
vaccin
antigen
gutassoci
lymphoid
tissu
galt
protect
antigen
pathogen
virus
ha
ha
express
l
lacti
induc
mucos
antibodi
l
lacti
express
bacteri
antigen
campylobact
jejuni
cjad
kobierecka
et
al
clostridium
difficil
tcda
yang
et
al
clostridium
perfringen
epsilon
toxoid
alimolaei
et
al
h
pylori
hpaa
ureaseb
kim
et
al
gu
et
al
zhang
et
al
v
cholera
wzm
zamri
et
al
also
induc
mucos
antibodi
preclin
model
dna
vaccin
proven
confer
protect
immun
varieti
infecti
agent
includ
hiv
herp
simplex
viru
hsv
plasmodium
spp
mtb
schoen
et
al
attract
featur
dna
vaccin
induc
humor
well
cellmedi
immun
respons
antibodi
alon
protect
mani
pathogen
toxin
cellmedi
immun
requir
protect
intracellular
pathogen
cancer
dna
vaccin
form
eukaryot
express
plasmid
deliv
either
intramuscular
inject
nake
dna
intraderm
bombard
use
dna
coat
gold
particl
help
gene
gun
electropor
follow
needl
inject
howev
method
induc
moder
level
protect
anim
model
fail
show
efficaci
clinic
trial
schoen
et
al
recent
year
mani
bacteri
vector
util
deliv
plasmid
host
cell
schoen
et
al
mani
attenu
strain
develop
deliveri
vaccin
antigen
similar
strain
also
util
deliv
plasmid
dna
vaccin
attenu
strain
gut
pathogen
includ
st
stm
l
monocytogen
particular
import
colon
infect
mucos
epitheli
cell
discuss
listeria
infect
begin
gastrointestin
tract
invas
intestin
mucosa
listeria
migrat
blood
vessel
lymph
organ
listeria
infect
wide
array
cell
type
includ
intestin
epitheli
cell
hepatocyt
dendrit
cell
macrophag
listeria
escap
phagocyt
vesicl
multipli
cytosol
releas
plasmid
listeriolysin
help
listeria
lyse
escap
phagosom
vacuol
liang
et
al
miki
et
al
engin
selfdestruct
lmbase
vaccin
deliv
eukaryot
express
plasmid
encod
mtb
antigen
mpb
vaccin
induc
protect
immun
respons
mtb
mous
model
miki
et
al
salmonella
also
infect
via
gastrointestin
tract
cross
epitheli
barrier
cell
salmonella
taken
macrophag
pham
mcsorley
salmonella
capabl
surviv
replic
phagocyt
vacuol
pham
mcsorley
howev
unknown
mechan
releas
plasmid
dna
cytosol
schoen
et
al
salmonella
strain
express
listeriolysin
shown
escap
phagosom
vesicl
cytosol
thu
make
gene
transfer
salmonella
effici
schoen
et
al
tcell
epitop
form
eukaryot
express
plasmid
deliv
attenu
stm
induc
ctl
well
antibodi
immun
respons
karpenko
et
al
anoth
studi
target
pneumonia
protect
antigen
psaa
pspa
deliv
stm
induc
mucos
iga
antigen
thu
immun
mice
protect
nasopharyng
colon
pneumonia
zhang
et
al
pathogen
parasit
trichinella
spirali
trypanosoma
cruzi
also
target
stmmediat
dna
vaccin
yang
et
al
construct
dna
vaccin
spirali
use
antigen
stm
deliveri
vehicl
mice
immun
oral
vaccin
induc
antigenspecif
mucos
iga
correl
protect
spirali
larval
challeng
salmonelladeliv
spirali
dna
vaccin
induc
immun
cytokin
yang
et
al
anoth
studi
mato
et
al
use
stm
deliv
cruzi
antigen
mice
via
oral
rout
immun
mice
elicit
specif
antibodi
higher
ratio
suggest
bia
vaccin
group
also
induc
strong
cellmedi
immun
mucos
iga
mato
et
al
bacteria
use
dna
deliveri
vehicl
design
disintegr
infect
host
cell
bacteri
dna
vaccin
vector
destroy
phagolysosom
reach
cell
cytoplasm
lead
ineffici
deliveri
plasmid
circumv
problem
variou
approach
devis
one
approach
take
advantag
phage
lysin
disintegr
reach
host
cell
cytosol
inclus
phage
lysin
significantli
improv
bactofect
bacteriamedi
deliveri
plasmid
dna
mammalian
cell
effici
phagocyt
well
nonphagocyt
cell
pilgrim
et
al
recent
kong
et
al
develop
univers
dna
vaccin
deliveri
platform
includ
sever
modal
enhanc
deliveri
immun
respons
cognat
antigen
attenu
stm
includ
capabl
escap
phagosom
compart
cytosol
host
cell
phagolysosom
degrad
kong
et
al
sifa
protein
direct
salmonellainduc
filament
format
salmonella
contain
endosom
vacuol
delet
sifa
gene
result
releas
salmonella
cytosol
henc
mutat
sifa
gene
salmonella
plasmid
carrier
allow
success
transfer
plasmid
dna
cytosol
host
cell
kong
et
al
kong
et
al
also
incorpor
element
guid
plasmid
nucleu
transcript
factor
bind
plasmid
carri
bind
sequenc
transport
nucleu
desir
antigen
transcrib
kong
et
al
salmonella
induc
apoptosispyroptosi
infect
cell
diminish
overal
transfect
effici
delet
tlpa
ssel
gene
significantli
reduc
apoptosi
host
cell
kong
et
al
moreov
salmonella
degrad
delay
due
regul
express
salmonella
lysi
program
allow
limit
number
replic
invas
therebi
ensur
optim
deliveri
plasmid
influenza
antigen
ha
deliv
platform
induc
enhanc
haspecif
igg
correl
protect
influenza
viru
challeng
kong
et
al
nineteenthcenturi
physician
william
b
coley
first
time
observ
regress
malign
tumor
one
patient
bacteri
infect
coley
went
develop
first
bacteri
therapi
cancer
use
kill
gramposit
bacteria
streptococci
gramneg
bacteria
serratia
marcescen
mixtur
call
coley
toxin
inject
patient
suffer
variou
form
cancer
result
partial
complet
regress
case
soft
tissu
sarcoma
longterm
diseasefre
surviv
achiev
approxim
patient
nevertheless
despit
remark
success
coley
toxin
advent
chemotherapi
radiotherapi
line
investig
prematur
abandon
bickel
et
al
howev
recent
year
approach
regain
attent
fact
bcg
current
use
immunotherapi
bladder
cancer
exhibit
superior
epirubicin
mitomycin
epirubicin
alon
fuge
et
al
sinc
first
report
bcg
use
cancer
treatment
preclin
clinic
investig
bcg
also
report
form
cancer
mice
preimmun
bcg
exhibit
slower
tumor
growth
compar
control
zheng
et
al
zheng
et
al
bacteria
specif
anaerob
exhibit
natur
tropism
toward
solid
tumor
phenomenon
although
poorli
understood
theoriz
certain
characterist
tumor
microenviron
facilit
phenomenon
deeper
pocket
tumor
devoid
new
blood
vessel
poorli
oxygen
show
limit
access
chemotherapeut
drug
lee
lin
et
al
forb
et
al
demonstr
stm
accumul
rate
compar
organ
includ
liver
spleen
lung
heart
skin
forb
et
al
use
vitro
model
kasinka
forb
demonstr
stm
exhibit
chemotaxi
depend
avail
specif
receptor
tsr
tar
trg
stm
differenti
attract
correspond
chemoattract
express
tumor
microenviron
serin
aspart
riboseglucos
wildtyp
strain
accumul
around
necrot
zone
insid
tumor
kasinska
forb
moreov
variou
immunosuppress
mechan
manifest
tumor
microenviron
also
support
prolifer
microb
lin
et
al
distinct
tumorhom
properti
microb
includ
lm
salmonella
har
deliv
variou
tumor
therapeut
modal
includ
therapeut
vaccin
antigen
dna
vaccin
anticanc
drug
variou
tumorassoci
antigen
taa
target
therapeut
vaccin
use
labv
deliveri
vehicl
psa
prostatespecif
antigen
secret
prostat
epitheli
cell
overexpress
malign
prostat
cell
attenu
lm
express
psa
lmllopsa
antigen
test
therapeut
vaccin
mous
tumor
model
express
human
psa
immun
lmllopsa
complet
regress
tumor
five
eight
mice
induc
psaspecif
cellular
immun
respons
immun
lmllopsa
significantli
increas
infiltr
psaspecif
cell
tumor
decreas
reg
cell
wallecha
et
al
overexpress
breast
cancer
potenti
target
immunotherapi
shahabi
et
al
engin
lmbase
vaccin
incorpor
antigen
elicit
cell
vaccin
caus
signific
delay
format
mammari
tumor
mice
tumorfre
till
week
experi
wherea
shamtreat
mice
develop
tumor
succumb
diseas
vaccin
also
result
signific
increas
tumorinfiltr
cell
decreas
intratumor
reg
cell
shahabi
et
al
p
aeruginosa
also
deliv
heterolog
antigen
use
type
iii
secret
system
experiment
model
bcell
melanoma
express
ovalbumin
ova
chauchet
et
al
demonstr
antitumor
efficaci
p
aeruginosabas
vaccin
express
ova
p
aeruginosa
induc
longlast
polyfunct
tcell
immun
respons
cognat
antigen
wherein
antigenspecif
cell
express
simultan
cell
also
show
enhanc
tumor
infiltr
properti
greater
ratio
effector
versu
regulatori
cell
chauchet
et
al
recent
mei
et
al
util
composit
approach
dna
vaccin
bacteri
surfac
express
achiev
tcellmedi
immun
target
tumorassoci
antigen
salmonellabas
vaccin
includ
aidai
autotransportermelan
murin
melanoma
antigen
fusion
protein
dna
vaccin
element
encod
two
murin
melanoma
epitop
mei
et
al
high
level
antigen
synthesi
multicopi
plasmid
exert
metabol
burden
labv
result
hyperattenu
low
colon
loss
viabil
importantli
poor
immunogen
variou
strategi
adapt
circumv
problem
includ
use
lowcopi
plasmid
use
vivo
induc
promot
ivip
use
arabinoseinduc
promot
loessner
et
al
among
first
promot
introduc
labv
p
nir
b
activ
anaerob
condit
p
pag
c
p
ssa
g
macrophageinduc
promot
salmonella
dunstan
directli
compar
immunogen
antigen
upon
express
antigen
regul
p
nir
b
p
pag
c
found
significantli
higher
antibodi
respons
p
pag
c
compar
p
nir
b
dunstan
et
al
arnold
et
al
achiev
differenti
antigen
express
vivo
use
vivo
induc
promot
p
pag
c
compris
variabl
ribosom
bind
site
rb
approach
strain
high
level
express
heterolog
protein
exhibit
low
level
colon
moder
amount
express
result
significantli
improv
infect
rate
mesenter
lymph
node
low
level
vivo
induc
antigen
express
result
unhamp
infect
compar
parent
strain
immunogen
depend
rate
infect
well
level
antigen
express
notabl
best
immun
respons
achiev
moder
level
antigen
express
infect
high
antigenexpress
strain
result
littl
immun
respons
hand
moder
level
immun
respons
gener
high
infect
low
antigen
express
arnold
et
al
wang
et
al
develop
regul
delay
antigen
synthesi
system
consist
laci
repressor
repress
transcript
p
trc
vitro
cultiv
arabinoseregul
promot
p
bad
drive
laci
express
vitro
medium
supplement
arabinos
upon
immun
lack
extern
arabinos
supplement
p
trc
derepress
lead
synthesi
antigen
regul
delay
antigen
synthesi
system
induc
equival
level
antibodi
protect
p
pag
ccontrol
antigen
synthesi
better
p
ssa
gcontrol
antigen
synthesi
upon
oral
immun
labv
must
withstand
acid
environ
stomach
success
colon
enter
pathogen
includ
e
coli
l
monocytogen
shigella
spp
l
lacti
toler
extrem
acid
ph
ph
possess
potent
acid
resist
ar
system
known
gdar
glutamatedepend
acid
resist
pathway
attenu
strain
st
stm
limit
acid
toler
exhibit
moder
immunogen
dharmasena
et
al
lp
play
import
role
surviv
infect
bacteria
howev
also
involv
toxic
host
variou
attempt
use
lp
oantigen
mutant
stm
result
poor
attach
intestin
invas
surviv
follow
oral
immun
regul
express
lp
oantigen
compon
express
vitro
time
immun
soon
colon
synthesi
stop
expect
achiev
maxim
infect
minim
toxic
kong
et
al
engin
salmonella
strain
lp
oantigen
synthesi
gene
rfc
rfah
kept
control
promot
aracp
bad
tightli
regul
arabinos
strain
highli
attenu
nevertheless
exhibit
superior
immunogen
kong
et
al
anoth
approach
detoxif
salmonella
lp
includ
remov
group
lipid
lp
kong
et
al
introduc
mani
method
employ
attenu
although
make
labv
strain
less
pathogen
safe
administ
high
dose
often
render
poorli
immunogen
due
inabl
circumv
physicochem
defens
host
moreov
inabl
penetr
mucos
barrier
also
make
poorli
immunogen
circumv
problem
curtiss
et
al
gener
regul
delay
attenu
system
rda
retain
full
virul
till
passag
gastrointestin
tract
infect
epitheli
cell
modifi
rda
strain
salmonella
virul
gene
fur
phopq
rpo
crp
express
control
aracp
bad
promot
arabinos
concentr
human
tissu
less
thu
vitro
strain
express
virul
gene
medium
supplement
arabinos
wherea
vivo
arabinos
depriv
mani
virul
gene
suppress
result
attenu
salmonella
approach
result
high
immunogen
combin
toler
high
dose
curtiss
et
al
order
evok
tcell
ctl
respons
antigen
need
deliv
cytoplasm
host
cell
variou
approach
use
accomplish
cytosol
deliveri
antigen
includ
use
type
iii
secret
system
directli
deliv
vaccin
antigen
host
cell
cytoplasm
use
ahemolysin
hlya
secret
system
e
coli
fulli
activ
salmonella
gentschev
et
al
hand
escap
endocyt
vacuol
also
feasibl
approach
unlik
lm
st
stm
reach
cytoplasm
infect
cell
elicit
tcell
respons
effect
compar
tcell
respons
cognat
antigen
chen
et
al
use
secret
signal
type
iii
secret
system
salmonella
outer
protein
e
sope
hlya
secret
signal
deliv
japonicum
antigen
salmonella
vaccin
construct
carri
lhdgst
fuse
hlya
secret
signal
sope
effect
express
deliv
antigen
cytoplasm
murin
macrophag
vitro
vaccin
construct
induc
type
respons
protect
japonicum
infect
chen
et
al
gentschev
et
al
report
two
listeri
antigen
deliv
stm
use
hlya
secret
signal
gener
protect
listeria
infect
gentschev
et
al
simultan
deliveri
two
listeri
antigen
llo
stm
use
yersinia
outer
protein
e
yope
carrier
molecul
salmonella
type
iii
secret
system
develop
lloand
cell
protect
murin
listeriosi
igw
et
al
sopemedi
deliveri
listeri
antigen
gener
tcellmedi
protect
listeria
infect
berchtold
et
al
make
bacteria
excel
vaccin
deliveri
vehicl
natur
abil
induc
potent
longlast
immun
respons
labv
possess
capac
induc
humor
well
cellmedi
immun
respons
humor
immun
respons
includ
serum
igg
mucos
igg
iga
cellmedi
immun
character
cell
ctl
iga
specif
implic
mucos
protect
variou
mucos
pathogen
cellmedi
immun
requir
intracellular
pathogen
note
subunit
vaccin
poor
capac
evok
mucos
well
cellmedi
immun
labv
also
shown
capac
overcom
immunosuppress
natur
variou
form
tumor
characterist
labv
togeth
tumortrop
capac
make
highli
suitabl
vector
cancer
immunotherapeut
vaccin
past
two
decad
tremend
progress
made
regard
labvmedi
deliveri
vaccin
antigen
prevent
varieti
viral
bacteri
parasit
diseas
recent
advanc
improv
safeti
immunogen
profil
sever
labv
platform
newgener
labv
withstand
harsh
physicochem
condit
gastrointestin
tract
exhibit
regul
attenu
regul
antigen
express
target
antigen
deliveri
labv
exhibit
effect
variou
preclin
preliminari
clinic
trial
tabl
howev
limit
number
clinic
trial
conduct
date
use
labv
due
potenti
safeti
concern
optim
would
result
versatil
safe
highli
immunogen
vaccin
deliveri
platform
ding
et
al
